Cargando…
Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge
INTRODUCTION: Almost 50% of the 17.5 million deaths worldwide from cardiovascular disease have been associated with systemic arterial hypertension (SAH). Into this scenario, Pharmaceutical Care (PC) has been inserted in order to improve the management of SAH and reduce its risks. OBJECTIVE: To evalu...
Autores principales: | Cazarim, Maurílio de Souza, de Freitas, Osvaldo, Penaforte, Thais Rodrigues, Achcar, Angela, Pereira, Leonardo Régis Leira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909302/ https://www.ncbi.nlm.nih.gov/pubmed/27304922 http://dx.doi.org/10.1371/journal.pone.0155204 |
Ejemplares similares
-
Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil
por: Cazarim, Maurílio de Souza, et al.
Publicado: (2018) -
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
por: Cazarim, Maurilio de Souza, et al.
Publicado: (2020) -
Effect of Medication Therapy Management by Pharmaceutical Care on Blood Pressure and Cardiovascular Risk in Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression
por: de Souza Cazarim, Maurilio, et al.
Publicado: (2023) -
Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus
por: Gonçalves, Ana Carolina Oliveira, et al.
Publicado: (2019) -
INSAF-HAS: a tool to select patients with hypertension for pharmaceutical care
por: Girolineto, Beatriz Maria Pereira, et al.
Publicado: (2019)